Deal Watch: Array Partners With Ono On Cancer Drugs In Japan, South Korea
French biotechs Servier and ILTOO sign an option agreement for the latter's IL-2 inhibitor for lupus, while Korean biotechs LegoChem and Bridge will team up in idiopathic pulmonary fibrosis.
